885273369	885273369	CD	B-NP	O
|	|	NN	I-NP	O
C	C	NN	I-NP	O
|	|	IN	B-PP	O
95441003	95441003	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9429816	9429816	CD	B-NP	O
|	|	CC	I-NP	O
5/13/2005	5/13/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
LLL	LLL	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/25/2005	7/25/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/19/2005	10/19/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
PAVIOLITIS	PAVIOLITIS	NNP	B-NP	O
,	,	,	O	O
BRYON	BRYON	NNP	B-NP	O
494-93-90-7	494-93-90-7	CD	I-NP	O
Gerillport	Gerillport	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/6/05	11/6/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KORINTA	KORINTA	NNP	B-NP	O
,	,	,	O	O
AMOS	AMOS	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DESIPRAMINE	DESIPRAMINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
HS	HS	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
DESCHOMP	DESCHOMP	NN	B-NP	O
,	,	,	O	O
BURT	BURT	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVAQUIN	LEVAQUIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
21437090	21437090	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DESIPRAMINE	DESIPRAMINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-VP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
TERP	TERP	NN	B-NP	B-protein
,	,	,	O	O
FORREST	FORREST	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVAQUIN	LEVAQUIN	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
25262147	25262147	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DESIPRAMINE	DESIPRAMINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
KRALLMAN	KRALLMAN	NNP	B-NP	O
,	,	,	O	O
LYNDON	LYNDON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
DESIPRAMINE	DESIPRAMINE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COLACE	COLACE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ROBITUSSIN	ROBITUSSIN	NNP	I-NP	O
AC	AC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GUAIFENESIN	GUAIFENESIN	NNP	I-NP	O
AC	AC	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	B-protein
Q4H	Q4H	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
If	If	IN	B-SBAR	O
sedated	sedate	VBN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/9/05	9/9/05	CD	B-NP	O
by	by	IN	B-PP	O
PRAT	PRAT	NN	B-NP	B-protein
,	,	,	O	O
CLYDE	CLYDE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ROBITUSSIN	ROBITUSSIN	NN	B-NP	O
AC	AC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
02277775	02277775	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Nausea/Vomiting	Nausea/Vomite	VBG	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TRAMADOL	TRAMADOL	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
keep	keep	NN	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

upright	upright	RB	B-ADVP	O
and	and	CC	O	O
prescribe	prescribe	VBP	B-VP	O
prn	prn	NN	B-NP	O
anti-emetic	anti-emetic	JJ	B-ADJP	O
.	.	.	O	O

SYNTHROID	SYNTHROID	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
175	175	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
REGLAN	REGLAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Nausea	Nausea	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
sedated	sedate	VBN	B-VP	O
or	or	CC	O	O
develops	develop	VBZ	B-VP	O
EPS/dystonic	EPS/dystonic	JJ	B-NP	B-protein
symptoms	symptom	NNS	I-NP	I-protein
LOPRESSOR	LOPRESSOR	NNP	B-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	IN	B-PP	O
5-10	5-10	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
oversedation	oversedation	NN	B-NP	O
,	,	,	O	O
rr	rr	NN	B-NP	O
<	<	SYM	I-NP	O
12	12	CD	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
EADIE	EADIE	NNP	B-NP	O
,	,	,	O	O
EDWARD	EDWARD	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
83639157	83639157	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Nausea/Vomiting	Nausea/Vomite	VBG	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TRAMADOL	TRAMADOL	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pharm	pharm	NN	B-NP	O
side-effect	side-effect	NN	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
true	true	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	B-DNA
PRAVACHOL	PRAVACHOL	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
PRAVASTATIN	PRAVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	,	O	I-DNA
40	40	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
110	110	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
TESSALON	TESSALON	NNP	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
COPD	COPD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
9	9	CD	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
apply	apply	RB	B-ADVP	O
to	to	TO	B-PP	O
undersides	underside	NNS	B-NP	O
of	of	IN	B-PP	O
B.breasts	B.breast	NNS	B-NP	O
/	/	SYM	B-VP	O
groin	groin	NN	B-NP	O
folds	fold	NNS	I-NP	O
,	,	,	O	O
thank	thank	IN	B-ADVP	O
you	you	PRP	B-NP	O
ADVAIR	ADVAIR	VBP	B-VP	O
DISKUS	DISKUS	NN	B-NP	B-protein
250/50	250/50	CD	I-NP	I-protein
-LRB-	-LRB-	SYM	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
SKULTETY	SKULTETY	NN	B-NP	O
,	,	,	O	O
ALFRED	ALFRED	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVAQUIN	LEVAQUIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
21437090	21437090	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-VP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
COHN	COHN	NN	B-NP	B-protein
,	,	,	O	O
ROSS	ROSS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVAQUIN	LEVAQUIN	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
25262147	25262147	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
by	by	IN	B-PP	O
RIVERIA	RIVERIA	NNP	B-NP	O
,	,	,	O	O
MARCOS	MARCOS	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NEXIUM	NEXIUM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
DICLOXACILLIN	DICLOXACILLIN	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Landolfo	Landolfo	NNP	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
to	to	TO	I-VP	O
reschedule	reschedule	VB	I-VP	O
if	if	IN	B-SBAR	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
make	make	VB	I-VP	O
appt	appt	NN	B-NP	O
Thurs	Thur	NNS	I-NP	O
9/2	9/2	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
LLL	LLL	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LLL	LLL	NNP	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
djd	djd	NN	I-NP	O
lumbar	lumbar	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
fusion	fusion	NN	I-NP	O
high	high	JJ	I-NP	O
chol	chol	NN	I-NP	O
h/o	h/o	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
incontinence	incontinence	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
'96	'96	CD	I-NP	O
essential	essential	JJ	I-NP	O
thrombocytosis	thrombocytosis	NN	I-NP	O
h/o	h/o	NN	I-NP	O
TIA	TIA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
laminectomy	laminectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
laminectomy	laminectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
L	L	NN	I-NP	O
knee	knee	NN	I-NP	O
meniscal	meniscal	JJ	I-NP	O
tear	tear	NN	I-NP	O
s/p	s/p	NN	I-NP	O
surgery	surgery	NN	I-NP	O
30	30	CD	I-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
meniscal	meniscal	JJ	I-NP	O
tear	tear	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
45-50	45-50	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
MRSA	MRSA	NN	I-NP	O
pna	pna	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
h/o	h/o	NN	I-NP	O
baker	baker	NN	I-NP	O
's	's	POS	B-NP	O
cyst	cyst	NN	I-NP	O
L.leg	L.leg	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
Bakers	Bakers	NNP	I-NP	O
cyst	cyst	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM2	DM2	NN	I-NP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBD	B-VP	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
cr	cr	NN	I-NP	O
1.4	1.4	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
anal	anal	JJ	I-NP	O
fissure	fissure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
anal	anal	JJ	I-NP	O
fissure	fissure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
incontinence	incontinence	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
incontinence	incontinence	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
82F	82F	NN	B-NP	O
w	w	NN	I-NP	O
``	``	``	B-NP	O
COPD	COPD	NN	I-NP	O
''	''	''	O	O
/	/	SYM	B-VP	O
smoke	smoke	NN	B-NP	O
inhalation	inhalation	NN	I-NP	O
injury	injury	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
FEV1	FEV1	CD	B-NP	O
1.56	1.56	CD	I-NP	O
68	68	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
FVC	FVC	NN	B-NP	B-protein
1.79	1.79	CD	I-NP	I-protein
,	,	,	O	O
ratio	ratio	NN	B-NP	B-protein
116	116	CD	I-NP	I-protein
,	,	,	O	O
on	on	IN	B-PP	O
cont	cont	NN	B-NP	O
2L	2L	NN	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
3V	3V	NN	B-NP	B-protein
CABG	CABG	NN	I-NP	I-protein
'96	'96	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
SVG	SVG	NN	I-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
PDA	PDA	NN	B-NP	B-protein
,	,	,	O	O
Diag1	Diag1	NN	B-NP	B-protein
;	;	:	O	O
cath	cath	NN	B-NP	O
'	'	''	I-NP	O
97	97	CD	I-NP	O
:	:	:	O	O
all	all	DT	B-NP	O
occluded	occlude	VBD	B-VP	O
,	,	,	O	O
PTCA	PTCA	NN	B-NP	O
to	to	TO	B-PP	O
PLV	PLV	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
diet	diet	NN	I-NP	O
controlled	control	VBD	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
last	last	JJ	B-NP	O
adm	adm	NN	I-NP	O
in	in	IN	B-PP	O
2/17	2/17	CD	B-NP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
pna/CHF	pna/CHF	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
USOH	USOH	NN	B-NP	O
until	until	IN	B-PP	O
9/9	9/9	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
slipped	slip	VBD	B-VP	O
and	and	CC	I-VP	O
fell	fall	VBD	I-VP	O
,	,	,	O	O
hurting	hurt	VBG	B-VP	O
her	her	PRP	B-NP	O
lower	low	JJR	B-ADJP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
R.wrist	R.wrist	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
no	no	DT	B-NP	O
fx	fx	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
sent	send	VBD	B-VP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
pain	pain	NN	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Represented	Represent	VBN	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
on	on	IN	B-PP	O
7/23	7/23	CD	B-NP	O
w	w	NN	I-NP	O
1d	1d	NN	I-NP	O
of	of	IN	B-PP	O
wheeze/cough	wheeze/cough	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

Worsened	Worsen	VBN	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
2d	2d	JJ	I-NP	O
pta	pta	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
increasing	increase	VBG	B-VP	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
SOB/DOE	SOB/DOE	NNP	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
.	.	.	O	O

P/to	P/to	NNP	B-NP	O
OCHN	OCHN	NNP	I-NP	O
where	where	WRB	B-ADVP	O
satting	satte	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
4L	4L	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
8L	8L	NN	I-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
ceftriax/azithro	ceftriax/azithro	NN	B-NP	O
,	,	,	O	O
20iv	20iv	JJ	B-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	O	O
nebs	neb	NNS	B-NP	O
,	,	,	O	O
125iv	125iv	NN	B-NP	O
solumedrol	solumedrol	NN	I-NP	O
,	,	,	O	O
2mg	2mg	NN	B-NP	O
iv	iv	NN	I-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	O	O
phenergan	phenergan	NN	B-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
there	there	RB	B-ADJP	O
notable	notable	JJ	I-ADJP	O
for	for	IN	B-PP	O
Cr	Cr	NN	B-NP	B-protein
1.7	1.7	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	I-protein
baseline	baseline	NN	B-NP	I-protein
1.4	1.4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
hct	hct	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
wbc	wbc	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
dirty	dirty	JJ	B-NP	O
UA	UA	NNP	I-NP	O
,	,	,	O	O
BNP	BNP	NNP	B-NP	O
852	852	CD	I-NP	O
,	,	,	O	O
ddimer	ddimer	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
LLL	LLL	NN	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Transferred	Transfer	VBN	B-VP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
another	another	DT	B-NP	O
20	20	CD	I-NP	O
iv	iv	NN	I-NP	O
lasix	lasix	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
neb	neb	NN	I-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
po	po	NN	I-NP	O
azithro	azithro	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
tramadol	tramadol	NN	B-NP	O
,	,	,	O	O
codeine	codeine	NN	B-NP	O
,	,	,	O	O
sulfa	sulfa	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
:	:	:	O	O
asa	asa	NN	B-NP	O
81	81	CD	I-NP	O
,	,	,	O	O
alb	alb	NN	B-NP	O
neb	neb	NN	I-NP	O
,	,	,	O	O
desipramine	desipramine	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
combivent	combivent	NN	B-NP	O
,	,	,	O	O
advair	advair	NN	B-NP	O
250/50	250/50	CD	I-NP	O
,	,	,	O	O
pravachol	pravachol	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
50	50	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
synthroid	synthroid	NN	B-NP	O
175	175	CD	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
temazepam	temazepam	NN	B-NP	O
15	15	CD	I-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
hydrea	hydrea	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
darvocet	darvocet	NN	B-NP	O
*	*	SYM	I-NP	O
FH/SH	FH/SH	NN	I-NP	O
:	:	:	O	O
Lives	Life	NNS	B-NP	O
below	below	IN	B-PP	O
son/daughter	son/daughter	NN	B-NP	O
.	.	.	O	O

Remote	Remote	JJ	B-NP	O
tob	tob	NN	I-NP	O
hx	hx	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
CXR	CXR	NN	B-NP	O
8/12/05	8/12/05	CD	I-NP	O
:	:	:	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
LLL	LLL	NN	B-NP	O
opacification	opacification	NN	I-NP	O
,	,	,	O	O
cephalization	cephalization	NN	B-NP	O
--	--	:	O	O
EKG	EKG	NN	B-NP	O
8/12/05	8/12/05	CD	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
at	at	IN	B-PP	O
71	71	CD	B-NP	O
bpm	bpm	NN	I-NP	O
,	,	,	O	O
QW	QW	NNP	B-NP	O
v1	v1	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
axis	axis	NN	I-NP	O
/	/	SYM	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
v1-2	v1-2	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
biphasic	biphasic	JJ	B-NP	O
TW	TW	NN	I-NP	O
in	in	IN	B-PP	O
v4	v4	NN	B-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
new	new	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
aVF	aVF	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
ECHO	ECHO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
2/17	2/17	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
HK	HK	NN	I-NP	O
w	w	NN	I-NP	O
wma	wma	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
RVE/decreased	RVE/decrease	VBN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
BAE	BAE	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
/	/	SYM	B-NP	O
tr	tr	NN	I-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
PAP	PAP	NN	B-NP	B-protein
61	61	CD	I-NP	I-protein
+	+	SYM	I-NP	O
RAp	RAp	NN	I-NP	B-protein
,	,	,	O	O
triv	triv	NN	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
--	--	:	O	O
PFTs	PFT	NNS	B-NP	O
-LRB-	-LRB-	SYM	O	O
2/3	2/3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
FEV1	FEV1	NN	B-NP	O
685	685	CD	I-NP	O
FVS	FVS	VBZ	B-VP	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
ratio	ratio	NN	B-NP	B-protein
116	116	CD	I-NP	I-protein
,	,	,	O	O
TLC	TLC	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RV	RV	NN	B-NP	O
48	48	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
DLCOc	DLCOc	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
*	*	SYM	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
T99	T99	NN	B-NP	O
.2	.2	CD	I-NP	O
P72	P72	NN	I-NP	B-protein
BP	BP	NN	I-NP	I-protein
145/59	145/59	CD	I-NP	I-protein
R22	R22	NN	I-NP	I-protein
O2sat	O2sat	NN	I-NP	I-protein
98	98	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
4L	4L	NN	I-NP	I-protein
Obese	Obese	NN	I-NP	I-protein
F	F	NN	I-NP	I-protein
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
,	,	,	O	O
hoarse	hoarse	NN	B-NP	O
voice	voice	NN	I-NP	O
,	,	,	O	O
frequent	frequent	JJ	B-NP	O
dry	dry	JJ	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
o/p	o/p	NN	B-NP	O
MMM	MMM	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
appreciated	appreciate	VBN	B-VP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
coarse	coarse	NN	I-NP	O
rhonchi	rhonchi	NN	I-NP	O
w	w	NN	I-NP	O
L.basilar	L.basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
BS	BS	NNP	B-NP	O
.	.	.	O	O

LE	LE	NN	B-NP	O
w	w	NN	I-NP	O
trace	trace	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
purplish-erythema	purplish-erythema	NN	I-NP	O
without	without	IN	B-PP	O
warmth	warmth	NN	B-NP	O
over	over	IN	B-PP	O
ankles	ankle	NNS	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
DP	DP	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
w	w	NN	I-NP	O
erythema	erythema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
calf	calf	NN	I-NP	O
pain	pain	NN	I-NP	O
/	/	SYM	B-NP	O
tenderness	tenderness	NN	I-NP	O
/	/	SYM	B-NP	O
cords	cord	NNS	I-NP	O
.	.	.	O	O

erm	erm	NN	B-NP	O
:	:	:	O	O
Erythema	Erythema	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
maceration	maceration	NN	I-NP	O
in	in	IN	B-PP	O
intertriginous	intertriginous	JJ	B-NP	O
areas	area	NNS	I-NP	O
under	under	IN	B-PP	O
breast	breast	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
warmth	warmth	NN	I-NP	O
or	or	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	SYM	O	O
82F	82F	NN	B-NP	O
w	w	NN	I-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
2-3	2-3	CD	B-NP	O
d	d	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
/	/	SYM	I-NP	O
DOE	DOE	NN	I-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
c/w	c/w	NN	I-NP	O
LLL	LLL	NN	I-NP	O
pna	pna	NN	I-NP	O
and	and	CC	O	O
mild-mod	mild-mod	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
likely	likely	RB	B-VP	O
precipiated	precipiate	VBN	I-VP	O
by	by	IN	B-PP	O
pna	pna	NN	B-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
abx	abx	NN	B-NP	O
,	,	,	O	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CVS	CVS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
I	I	PRP	B-NP	O
-RRB-	-RRB-	VBP	B-VP	O
:	:	:	O	O
Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
baby	baby	NN	B-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
nitrate	nitrate	NN	B-NP	O
,	,	,	O	O
low-dose	low-dose	JJ	B-NP	O
BB	BB	NN	I-NP	O
.	.	.	O	O

Chol	Chol	NN	B-NP	O
panel	panel	NN	I-NP	O
wnl	wnl	NN	I-NP	O
in	in	IN	B-PP	O
4/3	4/3	CD	B-NP	O
-LRB-	-LRB-	SYM	O	O
chol	chol	NN	B-NP	O
150	150	CD	I-NP	O
,	,	,	O	O
TG	TG	NN	B-NP	B-cell_line
127	127	CD	I-NP	I-cell_line
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
51	51	CD	I-NP	I-DNA
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
74	74	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Had	Have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
on	on	IN	B-PP	O
7/28	7/28	CD	B-NP	O
and	and	CC	I-NP	O
10/20	10/20	CD	I-NP	O
w	w	NN	I-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
w	w	NN	I-NP	O
dry	dry	JJ	I-NP	O
heaves	heave	NNS	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
min	min	NN	B-NP	O
.	.	.	O	O

changes	change	NNS	B-NP	O
-LRB-	-LRB-	VBP	B-VP	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
v3-4	v3-4	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
negative	negative	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
discomfort	discomfort	NN	I-NP	O
appeared	appear	VBD	B-VP	O
more	more	RBR	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
cough	cough	NN	B-NP	O
/	/	SYM	B-NP	O
retching	retching	NN	I-NP	O
than	than	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

CVS	CVS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
P	P	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Mild-mod	Mild-mod	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
20	20	CD	B-NP	O
po	po	NN	I-NP	O
lasix	lasix	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Attempted	Attempt	VBN	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
received	receive	VBD	B-VP	O
3	3	CD	B-NP	O
doses	dose	NNS	I-NP	O
total	total	JJ	B-ADJP	O
in	in	IN	B-PP	O
EDs	ED	NNS	B-NP	O
/	/	SYM	B-NP	O
floor	floor	NN	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
unclear	unclear	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Good	Good	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
iv	iv	IN	I-NP	O
lasix	lasix	CD	I-NP	O
x	x	SYM	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
neg	neg	NN	B-NP	O
neg	neg	NN	I-NP	O
1.6	1.6	CD	I-NP	O
L.	L.	NNP	I-NP	O
Wt	Wt	NNP	I-NP	O
down	down	IN	B-ADVP	O
from	from	IN	B-PP	O
97	97	CD	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
to	to	TO	B-PP	O
93.6	93.6	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
though	though	IN	B-SBAR	O
bed	bed	NN	B-NP	O
vs.	vs.	CC	B-PP	O
standing	stand	VBG	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
remained	remain	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
to	to	TO	B-PP	O
8-10cm	8-10cm	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
confounded	confound	VBN	I-VP	O
by	by	IN	B-PP	O
pt	pt	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
mild	mild	JJ	I-NP	I-protein
TR	TR	NN	I-NP	I-protein
.	.	.	O	O

O2sats	O2sat	NNS	B-NP	O
quickly	quickly	RB	B-ADVP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

Followed	Follow	VBN	B-VP	O
`	`	``	O	O
lytes	lyte	NNS	B-NP	O
,	,	,	O	O
strict	strict	JJ	B-NP	O
I/O	I/O	NN	I-NP	O
,	,	,	O	O
qd	qd	NN	B-NP	O
weights	weight	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
low-salt	low-salt	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
Cr	Cr	NN	B-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1.2-1	1.2-1	CD	B-NP	O
.4	.4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

CVS	CVS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
R	R	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

Maintained	Maintain	VBN	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
for	for	IN	B-PP	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

Tele	Tele	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
5b	5b	NN	B-NP	O
run	run	NN	I-NP	O
NSVT	NSVT	NN	I-NP	O
and	and	CC	O	O
several	several	JJ	B-NP	O
pauses	pause	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
<	<	SYM	B-NP	O
2sec	2sec	CD	I-NP	O
each	each	DT	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM/ID	PULM/ID	NN	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	O
d/o	d/o	NN	I-NP	O
lobar	lobar	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Covered	Cover	VBN	B-VP	O
with	with	IN	B-PP	O
vanc/levoflox	vanc/levoflox	NN	B-NP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
linezolid/levo	linezolid/levo	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
in	in	IN	B-PP	O
sputum	sputum	NN	B-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
cx	cx	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
showed	show	VBD	B-VP	O
Staph	Staph	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
MRSA	MRSA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
diclox	diclox	NN	B-NP	O
.	.	.	O	O

continued	continue	VBN	B-NP	O
advair	advair	NN	I-NP	O
,	,	,	O	O
duonebs	duoneb	NNS	B-NP	O
q4	q4	NN	I-NP	O
,	,	,	O	O
antitussive	antitussive	JJ	B-NP	O
,	,	,	I-NP	O
supplemental	supplemental	JJ	I-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
elev	elev	NN	I-NP	O
of	of	IN	B-PP	O
Cr	Cr	NN	B-NP	B-protein
?	?	.	O	O

2/2	2/2	CD	B-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
vs	vs	IN	B-PP	O
intravascular	intravascular	JJ	B-NP	O
vol	vol	NN	I-NP	O
depletion	depletion	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
redistribution	redistribution	NN	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
,	,	,	O	O
diuresed	diurese	VBD	B-VP	O
v.	v.	NN	B-NP	O
gently/cautiously	gently/cautiously	RB	B-ADVP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
stable	stable	JJ	I-NP	O
following	follow	VBG	I-NP	O
diuresis	diuresis	NN	I-NP	O
at	at	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
at	at	IN	B-PP	O
CH	CH	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
+	+	SYM	B-NP	O
LE	LE	NN	I-NP	O
/	/	SYM	B-NP	O
nitr	nitr	NN	I-NP	O
/	/	SYM	I-NP	O
20	20	CD	I-NP	O
wbc	wbc	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
cx	cx	NN	I-NP	O
here	here	RB	B-ADVP	O
neg	neg	NN	B-NP	O
w	w	NN	I-NP	O
100	100	CD	B-NP	O
GNR	GNR	NN	I-NP	O
.	.	.	O	O

Foley	Foley	NNP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
at	at	IN	B-PP	O
pshc	pshc	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
here	here	RB	B-ADJP	O
post-diuresis	post-diuresis	JJ	I-ADJP	O
on	on	IN	B-PP	O
1/24	1/24	CD	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
coughing	cough	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
likely	likely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
coughing/nebs	coughing/neb	NNS	B-NP	O
/	/	SYM	O	O
abx	abx	NN	B-NP	O
vs.	vs.	IN	B-PP	O
constipation	constipation	NN	B-NP	O
vs	vs	IN	B-PP	O
ischemia	ischemia	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Treated	Treat	VBN	B-VP	O
with	with	IN	B-PP	O
reglan	reglan	NN	B-NP	O
iv	iv	NN	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

KUB	KUB	NN	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
hct	hct	NN	B-NP	O
33.5	33.5	CD	I-NP	O
,	,	,	O	O
MCV	MCV	NN	B-NP	B-DNA
70	70	CD	I-NP	I-DNA
,	,	,	O	O
+	+	CC	O	O
iron	iron	NN	B-NP	O
def	def	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
Fe	Fe	NN	B-NP	O
31	31	CD	I-NP	O
in	in	IN	B-PP	O
4/9	4/9	CD	B-NP	O
,	,	,	O	O
TIBC	TIBC	NNP	B-NP	B-cell_line
445	445	CD	I-NP	I-cell_line
,	,	,	O	O
ferr	ferr	NN	B-NP	B-protein
32	32	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
No	No	DT	B-NP	O
scopes	scope	NNS	I-NP	O
on	on	IN	B-PP	O
record	record	NN	B-NP	O
.	.	.	O	O

Guaiced	Guaice	VBN	B-VP	O
all	all	DT	B-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	B-protein
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
30-34	30-34	CD	B-NP	O
.	.	.	O	O

Discuss	Discuss	NN	B-NP	O
outpatient	outpatient	NN	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
pt	pt	NN	B-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
wish	wish	VB	I-VP	O
to	to	TO	I-VP	O
pursue	pursue	VB	I-VP	O
this	this	DT	B-NP	O
option	option	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-NP	O
iron	iron	NN	I-NP	O
suppl	suppl	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

Covered	Cover	VBN	B-VP	O
here	here	RB	B-ADVP	O
w	w	NN	B-NP	O
RISS	RISS	NN	I-NP	O
.	.	.	O	O

ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

FS	FS	NNS	B-NP	O
ranged	range	VBD	B-VP	O
100-200s	100-200	NNS	B-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
HbA1c	HbA1c	NN	I-NP	O
in	in	IN	B-PP	O
4/3	4/3	CD	B-NP	O
was	be	VBD	B-VP	O
5.3	5.3	CD	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
0.556	0.556	CD	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
/	/	SYM	B-VP	O
fat/chol	fat/chol	NN	B-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
2L	2L	NN	B-NP	O
FR	FR	NN	I-NP	O
11	11	CD	I-NP	O
-RRB-	-RRB-	:	O	O
PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
12	12	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DERM	DERM	NN	I-NP	O
:	:	:	O	O
Nystatin	Nystatin	NN	B-NP	O
cream/miconazole	cream/miconazole	NN	I-NP	O
powder	powder	NN	I-NP	O
to	to	TO	B-PP	O
intertriginous	intertriginous	JJ	B-NP	O
areas	area	NNS	I-NP	O
.	.	.	O	O

H/o	H/o	NN	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
under	under	IN	B-PP	O
L.breast	L.breast	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
though	though	IN	B-SBAR	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
looked	look	VBD	B-VP	O
macerated	macerate	VBN	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
warm/tender	warm/tender	VB	I-VP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
still	still	RB	B-ADVP	O
candidiasis	candidiasis	NN	B-NP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
bacterial	bacterial	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
eval	eval	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
refused	refuse	VBD	B-VP	I-protein
rehab	rehab	NN	B-NP	I-protein
,	,	,	O	O
so	so	RB	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
home	home	NN	I-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
if	if	IN	B-SBAR	O
develop	develop	NN	B-NP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
.	.	.	O	O

chills	chill	NNS	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
cough	cough	NN	B-NP	O
please	please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

Complete	Complete	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
dicloxacillin	dicloxacillin	NN	I-NP	I-protein
as	as	IN	B-PP	O
directed	direct	VBN	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
as	as	IN	B-SBAR	O
arranged	arrange	VBN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Take	Take	NNP	I-NP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-VP	O
Call	Call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
worrisome	worrisome	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Consider	Consider	NNP	I-NP	O
outpt	outpt	VBD	B-VP	O
Colonoscopy	Colonoscopy	NNP	B-NP	O
to	to	TO	B-VP	O
work	work	VB	I-VP	O
up	up	RP	B-PRT	O
iron	iron	NN	B-NP	B-protein
deficiency	deficiency	NN	I-NP	I-protein
anemia	anemia	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
complete	complete	JJ	I-NP	O
10d	10d	CD	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
diclox	diclox	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MAFFETT	MAFFETT	NNP	B-NP	O
,	,	,	O	O
NESTOR	NESTOR	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
JK82	JK82	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/6/05	11/6/05	CD	I-NP	O
@	@	SYM	B-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

